Detalles de la búsqueda
1.
A large-scale systematic survey of SARS-CoV-2 antibodies reveals recurring molecular features
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-470157
2.
Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-492220
3.
Probing the biophysical constraints of SARS-CoV-2 spike N-terminal domain using deep mutational scanning
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-496903
4.
A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-991570
5.
Dynamics of B-cell repertoires and emergence of cross-reactive responses in COVID-19 patients with different disease severity
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20153114
6.
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-509341
7.
Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428356
8.
Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-427802
9.
Evidence of antigenic imprinting in sequential Sarbecovirus immunization
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-339465
10.
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-305441
11.
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-222232
12.
Structural basis of a public antibody response to SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-141267
13.
Human organoid systems reveal in vitro correlates of fitness for SARS-CoV-2 B.1.1.7
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-441080
14.
Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-431722
15.
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-430500
16.
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-430866
17.
Potent SARS-CoV-2 neutralizing antibodies selected from a human antibody library constructed decades ago
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-370676
18.
Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-233536
19.
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-993097
20.
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-437942